Shield Therapeutics Share Discussion Threads

[ttny2004] 01/5/2024 12:55

Well said!

[eringael] 01/5/2024 08:47

I get your point however if they do actually deliver over 17 months then this could indeed be a multibagger, at this level it's worth a punt with threat of near term finance requirements kicked down the road for a while and next update should ok with Texas issues resolved

[base7] 01/5/2024 08:29

Just watched Q & A & he gave a political answer in response to the question as to whether or he & other Directors would buy more shares.If he is as enthused as he says he is , confident of break even next year ,confident that China will happen & that we will reach cash flow break even in the second half of FY25-why on earth would he not now give that ultimate vote of confidence & buy a significant stake,eg 3% would cost him 6 months salary & if his anticipated success is achieved,£300k could become £3m-IF no cash raise needed & our share price crawls back to a lowly 13/14p over the next 18 months or so -should it not be a no brainer to such an optimistic CEO?

[qipincha] 01/5/2024 08:12

One of the BoD bought late last year

[base7] 01/5/2024 07:35

If STX has such incredible prospects why on earth are Greg & Directors not buying disclosable stakes as the opportunity for them to make many millions of $s must be like taking candy from the proverbial baby ?

[napoleon 14th] 30/4/2024 19:16

No, I started my stocks on internet experience on Share Crazy if that's what you mean.
It went downhill later.

[eringael] 30/4/2024 18:57

Hi Napoleon, yes just need to show consistent growth with no surprises on funding and we should progress - Did you used to be on shares form many moons ago?

[napoleon 14th] 30/4/2024 16:11

Haven't added here as (well underwater) the recovery has yet to be confirmed.
If they can sort Texas out & continue to progress it should be a multibagger,
but proof is in the pudding and not baked in yet.
Nevertheless, the presentation was good so I'm just LTBH here.

Another presentation today at 17:30 - SOU. Added this am. in my penny share PF 'cos
they're going to produce lots of gas in 2025 - the kit is being put in place.

Both of these have the potential to multibag from rock bottom prices!

[qipincha] 30/4/2024 15:42

regarding china, they said patient study complete this year and approval estimated in 2026

[qipincha] 30/4/2024 15:41

a few questions came from me, not completely happy with their answers.

but much clearer with the Texas situation, Q1 has a shortfall of ~3000 prescription, which is nearly 10% of the overall number. in theory, should see big improvement in Q2

also, mentioned milestone income possible this year

and confirmed the company will turn cash flow positive in H2 2025 with current finance arrangement

I missed the last bit due to a meeting, will watch the recording later.

[skcots48] 30/4/2024 15:32

Did they say why the China study was such an effing mess and now not scheduled to finish until 2025

[r9505571] 30/4/2024 15:17

H2 2026 for China approvalCanada still no decision expected 2024India?Est subscriptions 2024?Poor awareness and things moving very slow. Prescription date issue seems to have been resolved. Working closely with 3rd party data provider. Have heard enough. Got to go. GLA HOPEFULLY NO NEED TO RAISE MORE CAPITAL! Roll on H2 2025

[r9505571] 30/4/2024 15:05

It's question time. Does anyone want to put any questions to the panel?

[r9505571] 30/4/2024 15:01

Shield offers comprehensive patient access program for $25 per month. Positive increase in prior authorization (PA) submission rates and improvements in gross/net average net selling price. Field access team hired to provide education & support to offices regarding prior authorizations. $10m accounts receivable financing with favourable terms

[zeus19] 30/4/2024 14:54

Texas represented 35% of all prescriptions in H2 2023. Transitions in Medicaid PBN in Texas created significant inconsistencies in PA approvals for Medicaid prescriptions. The old PBM left in December and the new PBM didn't start until April 1st. Medicaid prescriptions for Texas dropped from 37% in Q4 23 to 19% in Q1. Shield were made aware that prescriptions weren't being approved in a timely manner by clinicians so they're actively engaging with the new PBM. This affected various drug manufacturers, not just Shield

[r9505571] 30/4/2024 14:53

Q1 2024 $4m net rev US Accrufer. 28,800 TRx's. $10.4 cash balance.Expand global patient access to Ferric MaltolStrong growth in California & NY +29% offset by a -28% decline in Texas.Texas represents 35% of all Accrufer TRx in 2H 2023. Transition in Medicaid PBM in Texas created significant inconsistencies in Prior Authorization (PA) approvals for Medicaid Prescriptions. New PBM in place on April 1st (Pharmacy Board Manager)

[r9505571] 30/4/2024 14:45

On the corporate presentation. Will try and post a summary.Aiming to turn cash positive in H2 in 2025.20m patients. 13.4m prescriptions per yearTotal available US market opportunity of $2.3bnGlobal partnerships continue to progress2023 Rev & other income of $17.5m. Av net selling price for Accrufer increased to $145 per prescription. Operating loss of $31.1mCash & cash equivalents of $13.9m

[zeus19] 30/4/2024 14:39

The uptrend continueshttps://openprescribing.net/analyse/?utm_medium=email&utm_campaign=monthly+alert+2024-04-30&utm_source=analyse-alerts&utm_content=%2Femail%2Fmonthly+alert+2024-04-30%2Fanalyse-alerts%2F1286#org=regional_team&numIds=0901011Y0&denomIds=9.1.1&selectedTab=chart

[purchaseatthetop] 30/4/2024 13:45

qipincha. you dont seem to understand the role of the PBM. In Texas the patients who have already been accepted will have prescriptions for between 12 and 24 months before they have to renew. OK...losing a PBM would mean a gradual drop over many months. But the impact in the first Q would be about zero. This has all the makings of being an excuse that will show up in 6 months as being worthless.

[qipincha] 30/4/2024 13:10

With calculation, the company seem controlled their spend to 3M per month, this is a good sign to me. I will join the meeting this afternoon and hopefully find out more

[hashertu] 30/4/2024 12:59

I was encouraged by that update.
I think and hope that they have passed through that inflection point that all new businesses go through.
So, definitely in glass half full mood.

[ny boy] 30/4/2024 12:28

Mr market does believe all these deluded views of positivity. I would say they are in a perilous state and definitely it an investment, think back a few years and look where they are, in the gutter. These companies need large injections of cash, can’t see where it’s coming from with the share price at virtually zero! Successive inexperienced BOD’s have right royally fuvked up but they get well paid, shareholders just lose their shirts. Avoid!